144 related articles for article (PubMed ID: 10460301)
21. Safety profile and clinical outcome of adjuvant radiation therapy and intermediate-dose interferon in comparison with intermediate-dose interferon alone in patients with melanoma metastases in regional lymph nodes and unfavorable prognostic factors.
Kukushkina M; Korovin S; Diedkov S; Ostafiichuk V; Diedkov A
Exp Oncol; 2021 Sep; 43(3):257-260. PubMed ID: 34591428
[TBL] [Abstract][Full Text] [Related]
22. Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both.
Moozar KL; Wong CS; Couture J
Can J Surg; 2003 Oct; 46(5):345-9. PubMed ID: 14577706
[TBL] [Abstract][Full Text] [Related]
23. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
[TBL] [Abstract][Full Text] [Related]
24. Malignant melanoma: a retrospective series from a regional cancer center in India.
Sharma K; Mohanti BK; Rath GK
J Cancer Res Ther; 2009; 5(3):173-80. PubMed ID: 19841558
[TBL] [Abstract][Full Text] [Related]
25. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
[TBL] [Abstract][Full Text] [Related]
26. Thermoradiation therapy for superficial malignant tumors.
Engin K; Leeper DB; Tupchong L; Waterman FM; Mansfield CM
Cancer; 1993 Jul; 72(1):287-96. PubMed ID: 8508420
[TBL] [Abstract][Full Text] [Related]
27. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients.
Schmid-Wendtner MH; Brunner B; Konz B; Kaudewitz P; Wendtner CM; Peter RU; Plewig G; Volkenandt M
J Am Acad Dermatol; 2000 Sep; 43(3):477-82. PubMed ID: 10954659
[TBL] [Abstract][Full Text] [Related]
28. Treatment of locally recurrent rectal carcinoma--results and prognostic factors.
Wong CS; Cummings BJ; Brierley JD; Catton CN; McLean M; Catton P; Hao Y
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):427-35. PubMed ID: 9457832
[TBL] [Abstract][Full Text] [Related]
29. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
30. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
31. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma.
Vongtama R; Safa A; Gallardo D; Calcaterra T; Juillard G
Head Neck; 2003 Jun; 25(6):423-8. PubMed ID: 12784232
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era.
Straker RJ; Song Y; Sun J; Shannon AB; Cohen LS; Muradova E; Daou H; Krause K; Li S; Frederick DT; Rhodin KE; Brizel DM; Boland GM; Beasley GM; Wuthrick EJ; Sondak VK; Zager JS; Lin A; Lukens JN; Karakousis GC
Ann Surg Oncol; 2021 Jul; 28(7):3512-3521. PubMed ID: 33230747
[TBL] [Abstract][Full Text] [Related]
34. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.
McLean N; Tighiouart M; Muller S
Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446
[TBL] [Abstract][Full Text] [Related]
35. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
36. Conventional radiotherapy in the treatment of lentigo maligna and lentigo maligna melanoma.
Harwood AR
J Am Acad Dermatol; 1982 Mar; 6(3):310-6. PubMed ID: 7068960
[TBL] [Abstract][Full Text] [Related]
37. Radiation therapy for nodal disease in malignant melanoma.
Burmeister BH; Smithers BM; Poulsen M; McLeod GR; Bryant G; Tripcony L; Thorpe C
World J Surg; 1995; 19(3):369-71. PubMed ID: 7638990
[TBL] [Abstract][Full Text] [Related]
38. Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.
Castle KO; Guadagnolo BA; Tsai CJ; Feig BW; Zagars GK
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):585-90. PubMed ID: 23628134
[TBL] [Abstract][Full Text] [Related]
39. [First melanoma metastases after 10 years and more of remission].
Peters A; Lippold A; Hundeiker M
Hautarzt; 1997 May; 48(5):311-7. PubMed ID: 9303904
[TBL] [Abstract][Full Text] [Related]
40. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
